Pura Vida Investments’s Acceleron Pharma XLRN Stock Holding History

Pura Vida Investments’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-64,400	Closed	-$11.1M	–	340
2021 Q3	$11.1M	Buy	+64,400	New	+$8.42M	0.34%	77

Pura Vida Investments's XLRN Position: Q3 2020 in Review

Pura Vida Investments sold out of Acceleron Pharma (XLRN) in Q3 2020, closing a stake of 20,400 shares — an estimated $1.94M sold.

Pura Vida Investments first reported a position in XLRN in Q1 2020 and held it in 2 quarters. The position peaked at $6.89M in Q1 2020. 238 funds tracked by Wall St. Rank hold XLRN as of Q3 2020.

Pura Vida Investments reported no remaining Acceleron Pharma position as of Q3 2020 after selling out during the quarter.
Pura Vida Investments sold 20,400 Acceleron Pharma shares in Q3 2020, an estimated $1.94M.
Pura Vida Investments first reported a position in Acceleron Pharma in Q1 2020 and held it in 2 quarters.
Pura Vida Investments's Acceleron Pharma position peaked at $6.89M in Q1 2020.
238 funds tracked by Wall St. Rank held Acceleron Pharma as of Q3 2020.

Based on Pura Vida Investments's 13F filing for Q3 2020, filed 16 Nov 2020.